CD79B (Polatuzumab Biosimilar) antibody
The Humanized Monoclonal anti-CD79B (Polatuzumab Biosimilar) antibody has been validated for FACS and ELISA. It is suitable to detect CD79B (Polatuzumab Biosimilar) in samples from Human.
1 image
Catalog No. ABIN7538759
-15% ABO 2026
$160.69
save $28.36 (-15 %)
Plus shipping costs $50.00
50 μg
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for CD79B (Polatuzumab Biosimilar) antibody (ABIN7538759)
Target
CD79B (Polatuzumab Biosimilar)
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD79B (Polatuzumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), ELISA
Grade
Research Grade
-
-
Purpose
- Anti-CD79B(polatuzumab biosimilar) mAb
-
Characteristics
- RO5541077, RG-7596
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Expiry Date
- 12 months
-
-
- CD79B (Polatuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- B29,IGB
-
UniProt
- P40259
Target
-
You are here:
